PARIS and CAMBRIDGE, Massachusetts, January 4, 2018 /PRNewswire/ --
- Proceeds will be used to progress lead development programs - EB8018 for IBD and EO2315 for cancer
- Secures €40 million loan facility ($48 million) from the European Investment Bank
ENTEROME SA, a...